Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Metsera (MTSR) Stock Forecast & Price Target

Metsera logo
Get the Latest News and Ratings for MTSR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Metsera and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MTSR Analyst Ratings Over Time

TypeCurrent Forecast
5/5/25 to 5/5/26
1 Month Ago
4/5/25 to 4/5/26
3 Months Ago
2/4/25 to 2/4/26
1 Year Ago
5/5/24 to 5/5/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$55.75$55.75$55.75$47.00
Forecasted Upside-20.92% Downside-20.92% Downside-20.92% Downside96.00% Upside
Consensus RatingHoldHoldHoldBuy

MTSR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MTSR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Metsera Stock vs. The Competition

TypeMetseraMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.30
2.52
Consensus RatingHoldHoldModerate Buy
Predicted Upside-20.92% Downside938.23% Upside14.74% Upside
News Sentiment Rating
Neutral News

See Recent MTSR News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/8/2025 Reiterated RatingSell (D)
9/30/2025
Cerena Chen
Not Rated
DowngradeOverweightEqual Weight$54.00+3.65%
9/24/2025
Leerink Partners logo
Leerink Partners
2 of 5 stars
 DowngradeStrong-BuyHold
9/3/2025Reiterated RatingOverweight
8/28/2025Boost TargetBuy$45.00 ➝ $50.00+37.44%
6/10/2025Boost TargetBuy$56.00 ➝ $62.00+70.66%
2/25/2025Initiated CoverageOutperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:33 AM ET.


MTSR Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Metsera is $55.75, with a high forecast of $62.00 and a low forecast of $50.00.

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Metsera in the last twelve months. There is currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MTSR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MTSR, but not buy additional shares or sell existing shares.

According to analysts, Metsera's stock has a predicted downside of -20.92% based on their 12-month stock forecasts.

Analysts like Metsera more than other "medical" companies. The consensus rating score for Metsera is 2.33 while the average consensus rating score for "medical" companies is 2.30. Learn more on how MTSR compares to other companies.


This page (NASDAQ:MTSR) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners